Information:
Fel:
ID
20448
Beskrivning
4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT00763568
Länk
https://clinicaltrials.gov/show/NCT00763568
Nyckelord
Versioner (1)
- 2017-02-22 2017-02-22 -
Uppladdad den
22 februari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Chronic Hepatitis C NCT00763568
Eligibility Chronic Hepatitis C NCT00763568
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis C NCT00763568
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
chronic hepatitis c
Item
chronic hepatitis c
boolean
C0524910 (UMLS CUI [1])
Combination peginterferon and ribavirin therapy prescribed (HEP-C); Absent response to treatment
Item
previously failed to respond to at least 12 weeks of peginterferon plus ribavirin combination therapy.
boolean
C1971490 (UMLS CUI [1,1])
C0438286 (UMLS CUI [1,2])
C0438286 (UMLS CUI [1,2])
unable to take oral medication
Item
unable to take oral medication.
boolean
C2222393 (UMLS CUI [1])
pregnancy, breast feeding, contraceptive methods
Item
females who are either pregnant, breast-feeding or not using birth control.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
C0006147 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
partner pregnant, gender
Item
males whose female partners are pregnant or plan to become pregnant.
boolean
C0919624 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
Comorbidity; Liver diseases | Hepatitis, Autoimmune | Decompensated liver disease
Item
other causes of liver disease (for example, autoimmune hepatitis, decompensated liver disease).
boolean
C0009488 (UMLS CUI [1,1])
C0023895 (UMLS CUI [1,2])
C0241910 (UMLS CUI [2])
C4075847 (UMLS CUI [3])
C0023895 (UMLS CUI [1,2])
C0241910 (UMLS CUI [2])
C4075847 (UMLS CUI [3])
hiv, hbv, hav, hdv
Item
patients with hiv, hav, hbv or hdv.
boolean
C0019682 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019159 (UMLS CUI [3])
C0011226 (UMLS CUI [4])
C0019163 (UMLS CUI [2])
C0019159 (UMLS CUI [3])
C0011226 (UMLS CUI [4])
Medical History; Substance Use Disorders; Alcohol consumption
Item
patients with a history of alcoholism or with an alcohol consumption of more than 40 grams per day.
boolean
C0262926 (UMLS CUI [1,1])
C0038586 (UMLS CUI [1,2])
C0001948 (UMLS CUI [1,3])
C0038586 (UMLS CUI [1,2])
C0001948 (UMLS CUI [1,3])
Hemoglobinopathies | Thalassemia | Anemia, Sickle Cell
Item
patients with hemoglobinopathies (for example, thalassemia major, sickle-cell anemia).
boolean
C0019045 (UMLS CUI [1])
C0039730 (UMLS CUI [2])
C0002895 (UMLS CUI [3])
C0039730 (UMLS CUI [2])
C0002895 (UMLS CUI [3])
hypersensitivity to nitazoxanide or peginterferon
Item
history of hypersensitivity or intolerance to nitazoxanide or peginterferon.
boolean
C0020517 (UMLS CUI [1,1])
C0068788 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0982327 (UMLS CUI [2,2])
C0068788 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0982327 (UMLS CUI [2,2])